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Abstract
Introduction—In an analysis of baseline findings of an HIV incidence cohort study, an 
assessment was made of HIV prevalence among persons presenting for enrollment and any 
differences in demographic characteristics between persons not enrolled compared to those 
enrolled. We also described and compared HIV risk behaviors in males and females enrolled in the 
study.
Methodology—A computer-assisted survey was administered to collect baseline demographic 
and HIV risk data from 1,277 men and women aged 18–34 years. Testing for HIV and other 
sexually transmitted infections (STI) was conducted. Out of 1,277 persons prescreened for 
eligibility, 625 were enrolled.
Results—HIV prevalence of all persons who completed screening was 14.8% (females: 21.1%; 
males: 8.1%). The odds of being enrolled in the study were higher for persons 18–24 years 
compared to those 30–34 years of age [adjusted odds ratio (AOR)=2.18, CI=1.13, 4.21] and males 
compared to females [AOR=2.07, CI=1.43, 2.99]. Among those enrolled in the study, the most 
prevalent HIV risk behaviors were unprotected sex (49%), alcohol use (45%), and transactional 
sex (30%) in the last three months. Compared to females, a significantly greater proportion of 
males reported using any alcohol or recreational drug in the last three months, a history of oral 
sex, sex with partner other than a spouse or main partner, ever having a blood transfusion, ever 
being treated for an STI, and having knowledge of their last HIV test result.
Conclusion—The Kisumu Field Station successfully recruited individuals with HIV risk 
characteristics for the HIV incidence cohort study.
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Introduction
The search for new HIV prevention interventions, such as vaccines, microbicides, pre-
exposure prophylaxis, and behavioral interventions, requires conducting randomized 
controlled clinical trials, the gold standard study design for establishing safety and efficacy 
for these interventions [1]. Preparation for such trials should target populations in settings of 
high HIV incidence or prevalence to be able to recruit persons at high risk for HIV and 
entails the development of the physical site, establishing cohorts of potential trial 
participants, building staff and laboratory capacity, and creating community awareness and 
engagement [2]. Experience gained during the process of preparing for cohort studies, 
especially measuring baseline HIV incidence, is essential to the planning and successful 
conduct of future trials of new prevention interventions [3–4].
Sub-Saharan Africa continues to be the region most heavily affected by the HIV epidemic. 
In 2007, the majority (69%) of adults with HIV worldwide lived in sub-Saharan Africa and 
72% of AIDS deaths occurred there [4]. The 2007 Kenya AIDS Indicator Survey estimated 
HIV prevalence among Kenyans aged 15 to 64 years as 7.1%, and identified Nyanza 
Province in western Kenya as having the highest HIV prevalence (14.9%) among the eight 
provinces of Kenya [5]. These figures were similar to national (6.7%) and Nyanza Province 
(15.1%) HIV prevalence estimates among Kenyans age 15 to 49 years [5].
Over the last decade, Kisumu, the administrative capital of Nyanza Province, has been an 
important location for HIV epidemiologic studies [6] and randomized controlled clinical 
trials of new interventions including male circumcision [7] and herpes suppression for HIV 
prevention among discordant couples [8]. As new effective interventions such as male 
circumcision are implemented and as potential changes in risk behavior may take place over 
time, it will be necessary to characterize the demographics and risk behavior of populations 
likely to be targeted for future trials of other HIV prevention interventions, and to document 
successful recruitment and enrollment of these individuals into HIV studies. Thus the 
purpose of this study is to describe characteristics of persons recruited and enrolled in an 
HIV vaccine preparatory cohort.
In January 2007, Kenya Medical Research Institute (KEMRI)/CDC initiated an HIV 
incidence cohort study to prepare for future community-based HIV vaccine (e.g., the 
planned Partnership for AIDS Vaccine Evaluation or PAVE 100 trial) or other prevention 
trials among young adults in Kisumu. The present analysis reports on the baseline findings 
of the cohort study which had the following primary objectives: 1) assess the prevalence of 
HIV among persons presenting for enrollment, and 2) determine if differences existed in 
demographic characteristics between persons not enrolled compared to persons enrolled. A 
secondary objective was to describe and compare HIV risk behaviors in males and females 
enrolled in the study. This paper will not report on HIV incidence or correlates of HIV 
infection. These findings will be presented in a separate analysis.
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Methodology
Study population and study site
The study was conducted in Kisumu, Nyanza Province, which has a population of 
approximately 500,000 residents that are predominately of Luo ethnicity [9]. The study 
catchment area comprised the city of Kisumu and bordering districts; a convenience sample 
approach was used. Criteria for participation included the following attributes: being HIV 
uninfected men and women (non-pregnant), 18 to 34 years of age who were sexually active 
within the three months prior to study enrollment and a resident of Kisumu or the 
surrounding area. The investigation was conducted at the study clinic of the KEMRI/CDC 
Clinical Research Center (CRC), which is adjacent to the New Nyanza Provincial General 
Hospital in Kisumu. All blood, urine, and vaginal specimens were processed and tested at 
the KEMRI/CDC ISO certified laboratory located at the CRC [10].
Overall study design
We established an observational, prospective cohort beginning January 2007 that involved 
pre-screening, screening, enrollment and 3-monthly visits for a total of 12 months of study 
follow-up. Persons who tested HIV positive post enrollment were followed for an additional 
period of 24 months following HIV positive diagnosis.
Ethical review
The study protocol, consent forms, and data collection instruments for this study were 
reviewed and approved by the KEMRI local and national Scientific Steering Committees 
and national Ethical Review Committee as well as the United States CDC Institutional 
Review Board.
Community engagement and recruitment
Community engagement focused on three key activities: establishing a community advisory 
board (CAB); creating ongoing dialogue and fostering involvement with community 
stakeholders; and implementing locally appropriate as well as research feasible community 
mobilization approaches. The CAB was comprised of 15 individuals from key categories in 
the local community including chiefs, religious leaders, teachers, persons living with HIV, 
youth, women’s groups, fishermen, local transportation, and other community-based 
organizations. The CAB served as a primary link between the community and the study 
staff. In addition to providing recommendations on how best to facilitate community 
awareness about the research study, the CAB advised on how to approach and negotiate 
interactions with influential community members, including community leaders, school 
heads, opinion leaders, and leaders of religious, women’s and youth groups.
Recruitment occurred in multiple venues such as market centers, truck stops, beaches, 
churches, women’s groups, community groups, formal and informal work-based groups, 
colleges and schools, and HIV Voluntary Counseling and Testing centers. In addition, we 
distributed brochures containing basic study information to potential study participants and 
invited interested persons to visit the study clinic for further information.
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We monitored numbers of potential participants coming to the study clinic daily. Due to low 
enrollment of women during the first two months of the study, recruitment strategies were 
altered from the first-come-first-served approach used initially to a sex-based quota system 
to enhance recruitment of women.
Baseline screening and enrollment procedures
Pre-screening for basic eligibility, informed consent, screening and enrollment procedures 
were conducted at the KEMRI/CDC CRC study clinic. All data collection instruments and 
consent documents were available in English and translated in local languages (Kiswahili 
and Dholuo). Study staff was fluent in all three languages and conducted procedures in each 
participant’s language of choice.
We performed a brief pre-screening assessment using interviewer-administered computer-
assisted personal interview (CAPI) to determine the first level eligibility criteria: engaged in 
sexual activity in last 3 months, not planning to move in next 12 months, willing to have an 
HIV test and receive results, not pregnant or plan to become pregnant in next 12 months, not 
in another HIV intervention study, never tested HIV positive, 18–34 years of age, resident of 
Kisumu catchment area, and willing to give locator information. Persons who met the pre-
screening criteria received detailed information about the study prior to providing written 
informed consent to proceed with screening procedures.
Screening procedures consisted of a baseline behavioral questionnaire using audio 
computer-assisted self-interview (ACASI); medical history; a clinical evaluation 
documented using CAPI; and a sample collection of blood, urine, and vaginal swabs. Male 
circumcision status was documented clinically. We tested for hemoglobin and platelet levels, 
liver and kidney function, sexually transmitted infections (STI: syphilis, HSV-2, chlamydia, 
gonorrhea), and pregnancy for women. Rapid HIV testing was conducted at the initial 
screening visit with pre- and post-test counseling.
We scheduled an appointment two weeks thereafter to deliver laboratory results and make 
available the final determination of study eligibility. The complete listing of study inclusion 
and exclusion criteria is shown in Table 1. If eligible, individuals were enrolled at that visit, 
issued a study photo identification card with a barcode, and detailed locator information was 
obtained; this was later verified by a home visit by study staff.
Individuals who tested HIV positive at baseline screening were provided with CD4 count 
results and referred to HIV care and treatment clinics. All participants received monetary 
transport reimbursement (300KSh or about $5 US per study visit). No other monetary 
incentives were provided for study participation.
Laboratory procedures
Haemoglobin and platelet counts were performed using the BD Coulter Counter (Beckman 
Coulter Inc., Roissy, France) to obtain a complete blood count from whole blood, while the 
liver and kidney functions were analyzed using the Cobas Integra 400 plus (Roche 
Diagnostics, Mannheim, Germany) from serum. Urine pregnancy testing was performed 
using First Sign HCG One Step (UNIMED International, Inc., South San Francisco, CA, 
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USA). Syphilis testing was conducted using a BD Macro-Vue RPR (Rapid Plasma Reagin) 
card test (BD & Company, Baltimore, USA) card test and all reactive tests were confirmed 
by Serodia TP-PA Syphilis Test (Fujirebio Inc, Tokyo, Japan).
HSV-2 was screened using HSV-2 IgG enzyme-linked immunoassay (ELISA) and infection 
with Chlamydia trachomatis or Neisseriae gonorrhoeae was evaluated by qualitative 
polymerase chain reaction, using COBAS AMPLICOR CT/NG (Roche Diagnostics, 
Mannheim, Germany). Real-time parallel rapid HIV testing was conducted using Uni-Gold 
HIV-1/2, (Trinity Biotech, Wicklow, Ireland) and Determine HIV-1/2 (Abbott Labs, Tokyo, 
Japan) with Bioline (Meridian Life Science Company, Cincinnati, Ohio) used as a tie-
breaker.
Analysis
To describe the sample and to compare enrolled males and females we computed 
frequencies, medians and Chi-square statistics. Because expected cell counts for some 
variables dropped below 5, we used Fisher’s exact test for all comparisons. A Wilcoxon test 
was used for continuous variables. In addition, we conducted bivariate and multiple 
regression analyses to determine demographic variables associated with being enrolled in 
the study or not. All demographic variables, regardless of their significance in bivariate 
analysis, were entered into the multiple logistic regression model. For HIV prevalence 
estimates, we calculated rates overall and by age and gender strata. Confidence intervals for 
these estimates were based on the binomial distribution.
Results
Between March 2007 and March 2008, a total of 1,277 individuals were prescreened for 
basic study eligibility, of whom 867 (68%) met preliminary criteria (Figure 1). Among the 
410 (32%) individuals initially excluded, reasons for the exclusions included sexual 
inactivity (n = 290, 70.7%), intention to move away from Kisumu (n = 139, 33.9%), 
intention to become pregnant (n = 61, 14.9%), and unwillingness to undergo HIV testing [n 
= 66 (38 male + 28 female; p = NS), 16.1%] or receive HIV test results [n = 59 (39 male 
+ 20 females; p = 0.10), 14.4%]. A few were excluded for other reasons such as current 
enrollment in an HIV intervention study (n = 29, 7.1%), previously tested HIV positive (n = 
16, 3.9%), unwillingness to come for study visits (n = 16, 3.9%) and current pregnancy (n = 
15, 3.7%). Among the 846 who met the criteria and completed the screening, 625 (48.9% of 
those recruited) were enrolled; 189 were not eligible after completing the ACASI 
questionnaire and laboratory testing. See Figure 1 for additional details regarding baseline 
screening and enrollment.
HIV prevalence among individuals presenting for enrollment
Among those who completed screening, overall HIV prevalence was 14.8% (125/846); 
21.5% among females (91/424) and 8.1% among males (34/422). Prevalence was 
significantly higher among females than males overall and in all age groups with the 
exception of the 30 to 34 years age group (Table 2). In addition, there was a significant 
difference in overall HIV prevalence among the three age groups (χ2(2) = 29.2; p < 0.001). 
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Pairwise comparisons showed that the 25 to 29 years (χ2(1) = 10.8; p < 0.001) and the 30 to 
34 years age groups (χ2(1) =24.8; p <0.001) had higher prevalence than the 18 to 24 years 
age group.
Enrolled compared to non-enrolled individuals: demographic characteristics
Differences were found in some demographic characteristics between enrolled and not 
enrolled persons, specifically in terms of age, gender, marital status, education, language 
preference, and migration history (Table 3). Compared to individuals not enrolled in the 
study, a greater proportion of individuals who were enrolled were younger (18 to 24 years) 
(p = 0.006), male (p < 0.001), single (p < 0.001), chose English as their ACASI language (p 
< 0.001), were a current student (p = 0.001), ever attended school (p = 0.005), completed a 
higher level of education (p < 0.001), and reported less than one week as their longest time 
out of town in the last three months (p = 0.002). In multivariate analysis, age, sex and 
language remained independently associated with enrollment. The odds of being enrolled 
were higher for persons 18 to 24 years compared to those 30 to 34 years of age [adjusted 
odds ratio (AOR) = 2.18, CI = 1.13, 4.21] and males compared to females [AOR = 2.07, CI 
= 1.43, 2.99]. The odds of being enrolled were lower for those who chose Dholuo for their 
ACASI language compared to English (AOR = 0.57, CI = 0.33, 0.99).
Enrolled compared to non-enrolled individuals: motivation for participation, male 
circumcision, HIV and STIs
A lower proportion of persons enrolled versus not enrolled reported their primary motivation 
for participation was due to incentives provided by the study (p = 0.015), tested positive for 
HSV-2 (p < 0.001), gonorrhea (p = 0.014) and syphilis (p = 0.008). There was no significant 
difference in male circumcision or chlamydia (Table 3). All persons enrolled had to be 
HIV-1 negative.
Enrolled males compared to enrolled females: sexual behaviors and other HIV risk 
behaviors
Overall, the most prevalent HIV risk behaviors were unprotected sex (49%), alcohol use 
(45%), and transactional sex (30%) in last the three months (Table 4). Compared to females, 
a greater proportion of males reported using any alcohol (p < 0.001) or any drug in the last 
three months (p < 0.001), a history of oral sex (p = 0.032), sex with partner other than a 
spouse or main partner in the last three months (p < 0.001), ever having a blood transfusion 
(p = 0.009), had an HIV test prior to screening (p < 0.042), and having knowledge of their 
last HIV test result (p = 0.016) (Table 4). Men also reported a younger age at sexual debut (p 
< 0.001), a greater number of lifetime partners (p < 0.001), a greater number of opposite sex 
partners in the last three months (p < 0.001), and also a greater number of times ever tested 
for an STI and number of lifetime HIV tests (p < 0.001).
Compared to males, a greater proportion of females reported being involved in a 
polygamous relationship (p = 0.026), a history of anal sex (p = 0.003), and a history of 
forced sex (p = 0.001).
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Discussion
Our analysis demonstrated the successful recruitment of young adults to assess HIV 
incidence and to prepare for future HIV prevention studies in this high HIV prevalence 
region of western Kenya. A total of 625 individuals were enrolled out of a total of 1,277 
prescreened. Among the 846 individuals who completed screening, 14.8% HIV prevalence 
was found among persons of previously unknown status compared to 14.9% HIV prevalence 
(15 to 64 years) for this area of Kenya reported in 2007 [5]. Recent studies in nearby areas in 
western Kenya reported an HIV prevalence of 15.4% among individuals aged 13 to 34 years 
[11] and 14.3% among individuals 18 to 55 years [12]. In these studies, as in many previous 
studies [5,13], we found a higher HIV prevalence among females than males, and increasing 
prevalence with increasing age emphasizing the disproportionate burden of disease among 
girls and women in sub-Saharan Africa [14].
In contrast to other similar studies, our analysis assessed differences between individuals 
enrolled and those not enrolled. While there were many similarities between these two 
groups, there were a few differences. The odds of being enrolled were higher for younger 
(18 to 24 years) compared to older persons and for men compared to women, and lower for 
persons who chose Dholuo for their ACASI language. That the enrolled group was younger 
and predominantly male represents the epidemiology of the epidemic in this population of 
western Kenya, specifically in that older individuals and females are more likely to be 
infected [11,12,15]. Our ability to enroll younger persons prior to HIV infection, however, is 
desirable for implementation of future HIV prevention trials in this population.
The difference in language preference for ACASI may be attributed to the higher proportion 
of people speaking English in the urban area where the study was conducted as compared to 
Dholuo being preferred more in the rural areas. Two additional results are worth noting. 
First, among all men screened, 46% were circumcised as determined by clinical 
examination. This is more than the 27.5% reported almost a decade earlier [16] and is 
expected considering the results of a study conducted in Kisumu, showing the protective 
effects of male circumcision for HIV infection [7]. Second, among individuals presenting for 
enrollment in our study, about 30% were excluded because they did not want an HIV test or 
did not want to know their results, perhaps due to concerns about potential negative social 
repercussions of being HIV infected, which has been reported in other studies [11,17]. 
Hopefully these fears of stigmatization will decrease with greater access to HIV treatment 
and other services in recent years so that HIV will be considered more of a chronic disease.
We also confirmed gender differences in sexual behaviors and other HIV risk behaviors that 
have been reported previously [13,18]. In addition to reporting an earlier age at sexual debut 
and a greater number of partners than women, men more frequently reported such risk 
behaviors as using alcohol, using recreational drugs, having sex with a partner other than a 
spouse or main partner, and having ever been treated for an STI. Problem alcohol drinking 
has been reported to be higher among men than women [19]. In addition, having sex while 
intoxicated has been associated with high risk of sexual behaviors such as unprotected sex 
with casual partners and paying for sex [20]. The 2000–2001 UNAIDS prevention 
campaign, titled “Men Make a Difference”, attempted to address this issue and worked to 
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motivate men and women to communicate about HIV risk behaviors such as alcohol and 
drug use and to encourage men to care for themselves and their partners and families [21].
The higher HIV prevalence among women not eligible for enrollment is likely due to 
multiple factors including HIV transmission being more efficient from infected men to 
uninfected women [22], young girls having sex with older men in exchange for gifts or 
favors [23], early marriage of adolescent girls which can lead to other health problems 
through early pregnancy [24], and the loss of educational opportunities [13,25,26]. 
Education is an effective means of HIV prevention in that it equips children to make 
informed decisions about their own health and at the same time contributes to the 
empowerment and economic independence of girls and women [27]. Other gender 
differences, such as unwanted or forced sex can be explained by the subordinate position of 
women in the society where many girls and women lack not only resources, but the ability to 
obtain resources, the ability to obtain leadership positions, and the power to make decisions 
[15,28]. It is noteworthy that there was no significant difference between men and women in 
the proportion reporting receiving food, shelter, money, gifts or other favors for sex in the 
last three months given that a key HIV risk factor in the literature is payment to girls and 
women for sex (e.g., Sugar Daddy) [29–31]. The literature is sparse regarding payment to 
boys/men for sex (“Sugar Mummies”), but gifts or favors from girls to boys has been 
reported as part of the dating ritual [30].
Our analysis findings should be interpreted in light of at least two potential limitations. First, 
our research participants were self-selected and may not be representative of the Kisumu 
population. Second, there may be response bias as with all surveys although we believe use 
of ACASI facilitated more honest responding [32]. The strength of our analysis, however, is 
that it provided information on both participants enrolled in the study and individuals who 
were not enrolled and the reasons that they were not enrolled.
In conclusion, in an area of Kenya with very high HIV prevalence, we successfully enrolled 
persons with HIV risk characteristics in an HIV incidence cohort. Overall, the enrolled and 
not enrolled groups were comparable with a few exceptions such as differences in age and 
gender. Gender-related differences in sexual behaviors and other HIV risk behaviors were 
similar to those previously reported in Kenya. Notably, females had higher HIV prevalence 
(21.5% versus 8.1%). This finding underscores the importance of focusing on adolescent 
girls and women to combat the HIV epidemic [33,34] via biomedical interventions such as 
microbicides [35] and/or structural/policy interventions such as education [36] which would 
provide girls with increased access to HIV knowledge, economic resources, and decision-
making power [37].
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Figure 1. 
Kisumu Incidence Cohort Study profile at baseline screening and enrollment
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Table 1
Inclusion and exclusion criteria for the Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–2008
Inclusion criteria
Male and female residents of the Kisumu catchment area
Age 18 to 34 years
Engagement in sexual activity ≥ one time within the past 3 months
HIV seronegative by licensed rapid HIV testing in parallel
Available for 12 months of participation in the study
Able and willing to provide informed consent
Able to provide detailed locator information to ensure adequate, timely follow-up
Meet the following laboratory criteria: serum creatinine < 1.5mg/dl, haemoglobin ≥ 9.0g/dl, platelets > 50,000/ml, ALT <
2.5 times the upper limit of normal
Willing to comply with study procedures and requirements if meet criteria for study eligibility
Exclusion criteria
HIV seropositive
Pregnant or plan to become pregnant in next 12 months if female
Plan to reside outside the Kisumu catchment area for >3 months
Evidence of clinically significant cardiac, respiratory, hepatic, gastrointestinal, endocrine, hematologic, psychiatric,
neurologic, or allergic disease that would compromise the ability of the participant to provide competent informed consent,
or to complete study procedures or study requirements as determined by the principal investigator or designated associate.
The clinical significance of any abnormality is to be evaluated in the context of the safety of the patient volunteer and the
objectives of this study.
Active participation in HIV intervention studies that might influence HIV incidence or risk behaviour
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Table 3
Baseline characteristics of persons screened for the Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–
2008, by enrollment status (N = 846)
Characteristic Screened and
enrolled
(N=625)a
n (%)
Screened and
not enrolled
(N=221)a
n (%)
p-value Total screened
(N=846)a
n(%)
Demographic characteristics
Age range (years)† 0.006
  18–24 485 (78) 150 (68) 635 (75)
  25–29 103 (16) 46 (21) 149 (17)
  30–34 37 (6) 25 (11) 62 (7)
Gender† <0.001
  Female 278 (44) 146 (66) 424 (50)
  Male 347 (56) 75 (34) 422 (50)
Marital status <0.001
  Single/Never married 407 (65) 108 (50) 515 (61)
  Not married, but living as married 55 (9) 17 (8) 72 (9)
  Married 144 (23) 70 (32) 214 (25)
  Separated/Divorced 14 (2) 14 (6) 28 (3)
  Widowed 4 (1) 9 (4) 13 (2)
District of residence 0.831
  Kisumu 611 (98) 218 (99) 829 (98)
  Vihiga 6 (1) 1(0) 7 (1)
  Nyando 8 (1) 2 (1) 10 (1)
Ethnic group or tribe 0.336
  Luo 527 (84) 182 (83) 709 (84)
  Luhya 55 (9) 25 (11) 80 (9)
  Kisii 28 (4) 5 (2) 33 (4)
  Kikuyu 5 (1) 4 (2) 9 (1)
  Maasai 1 (0) 0 (0) 1 (0)
  Other 9 (1) 4 (2) 13 (2)
Language chosen for ACASI interview† <.001
  English 352 (56) 76 (34) 428 (51)
  Kiswahili 82 (13) 41 (19) 123 (15)
  Dholuo 191 (31) 104 (47) 295 (35)
Religion 0.153
  Roman Catholic 226 (36) 92 (42) 318 (38)
  Protestant/other Christian 290 (46) 80 (36) 370 (44)
  Muslim 21 (3) 6 (3) 27 (3)
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Characteristic Screened and
enrolled
(N=625)a
n (%)
Screened and
not enrolled
(N=221)a
n (%)
p-value Total screened
(N=846)a
n(%)
  Nomiyab 31 (5) 14 (6) 45 (5)
  No religion 17 (3) 8 (4) 25 (3)
  Other 40 (6) 20 (9) 60 (7)
Education
  Currently a student- n (%) yes 187 (30) 41 (19) 0.001 228 (27)
  Ever attended school- n (%) yes 601 (96) 202 (92) 0.005 803 (95)
Highest level of schooling completed <0.001
  No school 22 (4) 18 (8) 40 (5)
  Primary 136 (22) 78 (35) 214 (25)
  Secondary 240 (39) 71 (32) 311 (37)
  Technical training 51 (8) 12 (5) 63 (7)
  College 160 (26) 40 (18) 200 (24)
  University 13 (2) 1 (0) 14 (2)
Employment
  Currently working 296 (47) 108 (49) 0.673 404 (48)
  Main type of work 0.823
    No work 328 (53) 112 (51) 440 (52)
    Farmer 22 (4) 6 (3) 28 (3)
    Salaried 17 (3) 5 (2) 22 (3)
    Casual worker 87 (14) 30 (14) 117 (14)
    Self-employed 101 (16) 45 (21) 146 (17)
    Homemaker 46 (7) 16 (7) 62 (7)
    Other 21 (3) 5 (2) 26 (3)
  Earned < minimum wage in the last 30
  Daysc
568 (94) 194 (94) 0.944 762 (94)
Migration history
Moved for ≥ 3 months within past 2 years- n (%) yes 194 (31) 68 (31) 0.940 262 (31)
Moved within the last 3 months- n (%) yes 72 (12) 30 (14) 0.420 102 (12)
Longest time out of town in the last 3 months 0.002
  None 189 (31) 93 (44) 282 (34)
  <1 week 236 (39) 56 (27) 292 (36)
  Between 1 week and 1 month 89 (15) 30 (14) 119 (14)
  >1 month 96 (16) 32 (15) 128 (16)
Motivation for participation
Free medical care for sexually transmitted infections
and common illness- n (%) yes
490 (79) 178 (81) 0.431 668 (79)
Incentives- n (%) yes 228 (37) 101 (46) 0.015 329 (39)
Circumcision, HIV and Sexually Transmitted
Infections
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Characteristic Screened and
enrolled
(N=625)a
n (%)
Screened and
not enrolled
(N=221)a
n (%)
p-value Total screened
(N=846)a
n(%)
Circumcised (males only) - n (%) yes 161 (47) 28 (38) 0.142 189 (46)
HIV-1 - n (%) positive
HSV-2 – n (%) positive
0 (0)
141 (24)
125 (57)
105 (53)
N/A
<0.001
125 (15)
246 (32)
Chlamydia – n (%) positive 19 (3) 5 (2) 0.550 24 (3)
Gonorrhea- n(%) positive
Syphilis – n (%) positive
10 (2)
6 (1)
10 (5)
8 (4)
0.014
0.008
20 (2)
14 (2)
aN for certain individual questions and laboratory results do not add up to total as some participants had missing data
b
Religion of the predominant Luo ethnic group in the area (38)
c
Less than Kenya Shillings 6130 earned in the last 30 days
†
Independently associated with enrollment in multivariable analysis.
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Table 4
Baseline characteristics of persons enrolled into the Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–
2008, by gender (N = 625)
Characteristic Males enrolled
(N=347)
Females
enrolled
(N=278)
p-value Overall
enrolled
(N=625)
Family characteristics
Head of household - n (%) yes 125 (36) 73 (26) <0.001 198 (32)
Parent - n (%) yes 103 (31) 148 (55) <0.001 251(42)
Partnership characteristics
>1 wife or co-wife at present - n (%) yes 2 (1) 8 (3) 0.026 10 (2)
History of ever inheriting a wife/being inherited† - n (%) yes 13 (4) 14 (5) 0.444 27 (4)
Alcohol and drug use in the last 3 months
Any alcohol use - n (%) yes 205 (59) 76 (27) <0.001 281 (45)
Any recreational drug use - n (%) yes 98 (28) 11 (4) <0.001 109 (18)
Any injecting drug use - n (%) yes 5 (1) 2 (1) 0.469 7 (1)
Sexual history
- Age at sexual debut – median (IQR) 15 (13–18) 17 (16–19) <0.001 16 (15–18)
-Number of lifetime sex partners-
median (IQR)
6 (3–10) 3 (2–4) <0.001 4 (2–8)
History of anal sex - n (%) yes 54 (16) 69 (25) 0.003 123 (20)
History of heterosexual oral sex - n (%) yes 99 (29) 58 (21) 0.032 157 (25)
History of forced sex - n (%) yes 45 (13) 65 (23) <0.001 110 (18)
Sexual risk behavior in the last 3 months
- Number of opposite sex sexual
partners- median (IQR)
2 (1–3) 1 (1–2) <0.001 1 (1–2)
-Had sex partner other than spouse or
main partner - n (%) yes
181 (53) 60 (22) <0.001 241 (39)
-Condom use last time had sex with spouse or main partner
n(%) no
158 (46) 147 (53) 0.156 305 (49)
-Thinks spouse or main partner had
sex with both men and women - n (%) yes
14 (4) 13 (5) 0.697 27 (4)
Forced sex - n (%) yes 29 (8) 37 (13) 0.046 66 (11)
Exchanged sex┼ (n (%) yes 114 (33) 73 (26) 0.074 187 (30)
Non-sexual risk characteristics^
Ever had a blood transfusion-
n (%) yes
65 (19) 31 (11) 0.009 96 (15)
Ever had scarification - n (%) yes 46 (13) 45 (16) 0.300 91 (15)
Ever been treated for a sexually
transmitted infection - n (%) yes
65 (19) 23 (8) <0.001 88 (14)
Treated for an STI in the last 3 months
- n (%) yes
16 (5) 5 (2) 0.053 21 (3)
HIV testing history and attitudes
Ever had an HIV test prior to 250 (72) 179 (65) 0.042 429 (69)
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Characteristic Males enrolled
(N=347)
Females
enrolled
(N=278)
p-value Overall
enrolled
(N=625)
screening - n (%) yes
- Lifetime number of times ever tested
for HIV- median (IQR)
2 (0–3) 1 (0–3) <0.001 1 (0–3)
Knows result of last HIV test –
n (%) yes
221 (64) 151 (55) 0.016 372(60)
†
“Inherited” refers to the cultural practice of the Luo, the predominant ethnic group in the area, where a widow is inherited by the male next of kin 
of the deceased husband (39).
┼includes exchanging sex for shelter, food, money, and/or gifts/other favors.
^Circumcisions status was not compared because it was clinically determined for males and self-reported for females.
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